< Back to companies1
AHA-21-Repurpose a novel anti-inflammatory for POAF
Bring to market a novel anti-inflammatory with proven pre-clinical efficacy and safety for Post Operative Atrial Fibrilation (POAF)
Company Info
Categories
Medical DeviceClinical InterventionsOrthopedicsHospital SolutionsPreventionPatient and Provider Tools
MedStartr Index Score
?What do you think of AHA-21-Repurpose a novel anti-inflammatory for POAF?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.